Wolfe Research analyst Timna Tanners initiates coverage on Kaiser Aluminum (NASDAQ:KALU) with a Peer Perform rating.
AnaptysBio Sells Royalty Interest In Cancer Drug For $45M
AnaptysBio Inc (NASDAQ:ANAB), a clinical-stage biotechnology company focused on immunology therapeutics, has sold its royalty interest on future global…